Jesper Lind
Plus aucun poste en cours
Profil
Jesper Lind worked as an Engineer at Alfa Laval AB and as Head-Enabling Capability at AstraZeneca AB.
He then served as Chief Operating Officer at Orexo AB from 2013 to 2018 and as Head-Supply at Moberg Pharma AB.
Mr. Lind graduated from The University of Sydney and the Royal Institute of Technology.
Anciens postes connus de Jesper Lind
| Sociétés | Poste | Fin |
|---|---|---|
| OREXO AB | Chief Operating Officer | 31/12/2018 |
| MOBERG PHARMA AB | Corporate Officer/Principal | - |
| ALFA LAVAL AB | Corporate Officer/Principal | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Formation de Jesper Lind
| The University of Sydney | Graduate Degree |
| Royal Institute of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ALFA LAVAL AB | Producer Manufacturing |
| OREXO AB | Health Technology |
| MOBERG PHARMA AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
